The general research approach of Berlin Institute of Health combines translational research with an overarching systems medicine approach. This means that results of basic research will be transferred into medical therapies, diagnosis, and prevention in a faster and more targeted way, and clinical observations will be taken up more quickly by basic research. In other words, a knowledge transfer occurs "from bench to bedside and from bedside to bench". Research results may stem from various specialized areas – medicine, biology, chemistry, physics, mathematics, information technology, and the social sciences.

Systems medicine is based on an understanding that the human body is a complex system consisting of dynamic, interconnected networks of molecules, cells, and tissues. Research in systems medicine involves the study of molecular mechanisms in the human body in an integrative manner. Rather than diseases being understood as the malfunction of individual cells or organs, attention is paid to overarching processes influencing both health and disease. Clinical symptoms can have a number of molecular causes, and inversely a genetic defect can spark various diseases. For example, inflammatory disease can affect various organs including the skin, the intestines, and the lungs.

Systems medicine at BIH means pursuing a process of reciprocal exchange between basic biomedical research, clinical research, and medical practice. Establishing this process thus forms an essential part of fulfilling our mission to make scientific and technological developments in systems medicine accessible for designing new preventive measures, diagnosis, and therapy.

Research groups at BIH

People are at the heart of BIH’s work, and we aim to attract, develop and retain the brightest minds of trans ­lational research and management.

Read more

Sektionen + Wiss. Infrastruktur

Events

    • In Memory of Professor Dr. Ernst Theodor Rietschel

      The Berlin Institute of Health at Charité (BIH) mourns the passing of Professor Dr Dr h.c. mult. Ernst Theodor Rietschel, the founding director and first Chairman of the Board of Directors of the Berlin Institute of Health. He passed away on 20 October 2026 at the age of 85.

      Read more
      • A Digital Safety Net for Women with Metastatic Breast Cancer

        How can patients receive better support in their everyday lives when living with advanced breast cancer? For Breast Cancer Awareness Month in October, we spoke with Prof. Maria Karsten, Senior Consultant at the Breast Center of Charité – Universitätsmedizin Berlin. Her digital solution ida recently …

        Read more

      Contact